Literature DB >> 19444482

Inappropriate left ventricular mass in children and young adults with chronic renal insufficiency.

Francesca Raimondi1, Marcello Chinali, Daniela Girfoglio, Margherita Benincasa, Luciano Pasquini, Francesco Emma, Giovanni de Simone, Maria Chiara Matteucci.   

Abstract

Increased left ventricular (LV) mass (M) in children with chronic renal insufficiency (CRI) might represent an adaptive mechanism to compensate for increased workload. We hypothesized that in children with CRI, pre-dialysis, values of left ventricular mass (LVM) exceed compensatory values for individual cardiac load. Complete anthropometric characteristics, biochemical profile and echocardiograms were obtained for 33 children with CRI, pre-dialysis (age 1-23 years, mean 12.2 +/- 5.0 years), and 33 age- and gender-matched healthy controls. LV dimensions, wall thicknesses and volume were measured. Endocardial and midwall shortening, ejection fraction, LVM, LVM index, relative wall thickness, circumferential wall stress and excess LVM (as ratio of observed LVM to value predicted from body size, gender and cardiac workload) were analysed. Patients with CRI showed higher values of LVM index, resulting in higher prevalence of LV hypertrophy (36.3% vs 9%, P < 0.05). The ratio of excess LVM was greater in patients with CRI than in healthy controls (126 +/- 19% and 103 +/- 13%, respectively, P < 0.001). LV ejection fraction, midwall fractional shortening and stress-corrected midwall shortening were lower in patients with CRI than in controls. We concluded that, in children with CRI, the values of LVM are higher than those needed to sustain individual cardiac load than in healthy controls, a condition associated with LV hypertrophy and reduced systolic performance.

Entities:  

Mesh:

Year:  2009        PMID: 19444482     DOI: 10.1007/s00467-009-1201-2

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  48 in total

1.  Misrepresentation of left ventricular contractile function by endocardial indexes: clinical implications after coarctation repair.

Authors:  T L Gentles; S P Sanders; S D Colan
Journal:  Am Heart J       Date:  2000-10       Impact factor: 4.749

Review 2.  Sympathetic overdrive and cardiovascular risk in the metabolic syndrome.

Authors:  Guido Grassi
Journal:  Hypertens Res       Date:  2006-11       Impact factor: 3.872

3.  Reduced systolic myocardial function in children with chronic renal insufficiency.

Authors:  Marcello Chinali; Giovanni de Simone; Maria Chiara Matteucci; Stefano Picca; Antonio Mastrostefano; Ali Anarat; Salim Caliskan; Nikola Jeck; Thomas J Neuhaus; Amira Peco-Antic; Licia Peruzzi; Sara Testa; Otto Mehls; Elke Wühl; Franz Schaefer
Journal:  J Am Soc Nephrol       Date:  2007-01-10       Impact factor: 10.121

Review 4.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

Authors:  N B Schiller; P M Shah; M Crawford; A DeMaria; R Devereux; H Feigenbaum; H Gutgesell; N Reichek; D Sahn; I Schnittger
Journal:  J Am Soc Echocardiogr       Date:  1989 Sep-Oct       Impact factor: 5.251

5.  Left ventricular abnormalities in children, adolescents and young adults with renal disease.

Authors:  L M Johnstone; C L Jones; L E Grigg; J L Wilkinson; R G Walker; H R Powell
Journal:  Kidney Int       Date:  1996-09       Impact factor: 10.612

6.  Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors.

Authors:  M M Mitsnefes; S R Daniels; S M Schwartz; R A Meyer; P Khoury; C F Strife
Journal:  Pediatr Nephrol       Date:  2000-09       Impact factor: 3.714

7.  Myocardial function and geometry in hypertensive subjects with low levels of afterload.

Authors:  Gerard P Aurigemma; Richard B Devereux; Giovanni De Simone; Mary J Roman; Michael J O'Grady; Michael Koren; Michael Alderman; John Laragh
Journal:  Am Heart J       Date:  2002-03       Impact factor: 4.749

8.  Antihypertensive and antiproteinuric efficacy of ramipril in children with chronic renal failure.

Authors:  Elke Wühl; Otto Mehls; Franz Schaefer
Journal:  Kidney Int       Date:  2004-08       Impact factor: 10.612

9.  Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension.

Authors:  G de Simone; R B Devereux; M J Roman; A Ganau; P S Saba; M H Alderman; J H Laragh
Journal:  J Am Coll Cardiol       Date:  1994-05       Impact factor: 24.094

10.  Echocardiographic patterns in infants and children with chronic renal failure.

Authors:  J B Palcoux; M C Palcoux; J P Jouan; J M Gourgand; J Cassagnes; G Malpuech
Journal:  Int J Pediatr Nephrol       Date:  1982-12
View more
  4 in total

1.  Left ventricular mass and systolic function in children with chronic kidney disease-comparing echocardiography with cardiac magnetic resonance imaging.

Authors:  Raoul Arnold; Daniel Schwendinger; Sabine Jung; Martin Pohl; Bernd Jung; Julia Geiger; Charlotte Gimpel
Journal:  Pediatr Nephrol       Date:  2015-09-05       Impact factor: 3.714

Review 2.  Cardiovascular complications in children with chronic kidney disease.

Authors:  Rukshana Shroff; Donald J Weaver; Mark M Mitsnefes
Journal:  Nat Rev Nephrol       Date:  2011-09-13       Impact factor: 28.314

3.  Magnetic resonance tissue phase mapping demonstrates altered left ventricular diastolic function in children with chronic kidney disease.

Authors:  Charlotte Gimpel; Bernd A Jung; Sabine Jung; Johannes Brado; Daniel Schwendinger; Barbara Burkhardt; Martin Pohl; Katja E Odening; Julia Geiger; Raoul Arnold
Journal:  Pediatr Radiol       Date:  2016-12-13

4.  Oxidative Stress Biomarkers and Left Ventricular Hypertrophy in Children with Chronic Kidney Disease.

Authors:  Dorota Drożdż; Przemko Kwinta; Krystyna Sztefko; Zbigniew Kordon; Tomasz Drożdż; Monika Łątka; Monika Miklaszewska; Katarzyna Zachwieja; Andrzej Rudziński; Jacek Antoni Pietrzyk
Journal:  Oxid Med Cell Longev       Date:  2016-01-18       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.